Quantitative analysis of the TNF-α-induced phosphoproteome reveals AEG-1/MTDH/LYRIC as an IKKβ substrate

Nature Communications

Volumn 6, Issue , 2015, Pages

  Krishnan, Ramesh K ^a   Nolte, Hendrik ^a,c   Sun, Tianliang ^a   Kaur, Harmandeep ^a   Sreenivasan, Krishnamoorthy ^a   Looso, Mario ^a   Offermanns, Stefan ^a,b   Krüger, Marcus ^a,c   Swiercz, Jakub M ^a  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ASTROCYTE ELEVATED GENE 1; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE PROTEIN; METADHERIN; PHOSPHOPROTEIN; PHOSPHOTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; I KAPPA B; I KAPPA B KINASE; I KAPPA B KINASE ALPHA; IKBKB PROTEIN, HUMAN; MTDH PROTEIN, HUMAN; NFKBIA PROTEIN, HUMAN; SERINE; TUMOR NECROSIS FACTOR;

BIOINFORMATICS; CANCER; GENE EXPRESSION; IMMUNE RESPONSE; INHIBITOR; PROTEOMICS; PUBLIC HEALTH; QUANTITATIVE ANALYSIS; SUBSTRATE; SURVIVAL;

ARTICLE; BIOINFORMATICS; CANCER PATIENT; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; FEMALE; GENE EXPRESSION; HEK293 CELL LINE; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MCF 7 CELL LINE; QUANTITATIVE ANALYSIS; RANDOM FOREST; UPREGULATION; CHROMATIN IMMUNOPRECIPITATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY; MCF-7 CELL LINE; METABOLISM; PHOSPHORYLATION; TUMOR STEM CELL ASSAY; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL ADHESION MOLECULES; CHROMATIN IMMUNOPRECIPITATION; CHROMATOGRAPHY, LIQUID; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; I-KAPPA B KINASE; I-KAPPA B PROTEINS; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MCF-7 CELLS; NF-KAPPA B; NF-KAPPAB INHIBITOR ALPHA; PHOSPHOPROTEINS; PHOSPHORYLATION; SERINE; TUMOR NECROSIS FACTOR-ALPHA; TUMOR STEM CELL ASSAY; UP-REGULATION;

EID: 84926628816     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7658     Document Type: Article

References (70)

1. Oeckinghaus, A., Hayden, M. S. & Ghosh, S. Crosstalk in NF-kappaB signaling pathways. Nat. Immunol. 12, 695-708 (2011).
2. Hayden, M. S. & Ghosh, S. Signaling to NF-kappaB. Genes Dev. 18, 2195-2224 (2004).
3. Chen, L. F. & Greene, W. C. Shaping the nuclear action of NF-kappaB. Nat. Rev. Mol. Cell Biol. 5, 392-401 (2004).
4. Pasparakis, M., Luedde, T. & Schmidt-Supprian, M. Dissection of the NFkappaB signalling cascade in transgenic and knockout mice. Cell Death Differ. 13, 861-872 (2006).
5. Polley, S. et al. A structural basis for IkappaB kinase 2 activation via oligomerization-dependent trans auto-phosphorylation. PLoS Biol. 11, e1001581 (2013).
6. Lee, D. F. et al. IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 130, 440-455 (2007).
7. Soule, H. D., Vazguez, J., Long, A., Albert, S. & Brennan, M. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl Cancer Inst. 51, 1409-1416 (1973).
8. Breiman, L. Random forests. Mach. Learn. 45, 5-32 (2001).
9. Franco, M. et al. The adaptor protein Tom1L1 is a negative regulator of Src mitogenic signaling induced by growth factors. Mol. Cell. Biol. 26, 1932-1947 (2006).
10. Wang, T., Liu, N. S., Seet, L. F. & Hong, W. The emerging role of VHS domaincontaining Tom1, Tom1L1 and Tom1L2 in membrane trafficking. Traffic 11, 1119-1128 (2010).
11. Vandenabeele, P., Galluzzi, L., Vanden Berghe, T. & Kroemer, G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat. Rev. Mol. Cell Biol. 11, 700-714 (2010).
12. Degterev, A. et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat. Chem. Biol. 4, 313-321 (2008).
13. Izumi, T. Physiological roles of Rab27 effectors in regulated exocytosis. Endocr. J. 54, 649-657 (2007).
14. Velikkakath, A. K., Nishimura, T., Oita, E., Ishihara, N. & Mizushima, N. Mammalian Atg2 proteins are essential for autophagosome formation and important for regulation of size and distribution of lipid droplets. Mol. Biol. Cell 23, 896-909 (2012).
15. Britt, D. E. et al. Identification of a novel protein, LYRIC, localized to tight junctions of polarized epithelial cells. Exp. Cell Res. 300, 134-148 (2004).
16. Sutherland, H. G., Lam, Y. W., Briers, S., Lamond, A. I. & Bickmore, W. A. 3D3/lyric: a novel transmembrane protein of the endoplasmic reticulum and nuclear envelope, which is also present in the nucleolus. Exp. Cell Res. 294, 94-105 (2004).
17. Brown, D. M. & Ruoslahti, E. Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell 5, 365-374 (2004).
18. Su, Z. Z. et al. Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH. Oncogene 21, 3592-3602 (2002).
19. Thirkettle, H. J. et al. LYRIC/AEG-1 is targeted to different subcellular compartments by ubiquitinylation and intrinsic nuclear localization signals. Clin. Cancer Res. 15, 3003-3013 (2009).
20. Zhu, K. et al. Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin. Cancer Res. 17, 7294-7302 (2011).
21. Meng, X. et al. Knockdown of MTDH sensitizes endometrial cancer cells to cell death induction by death receptor ligand TRAIL and HDAC inhibitor LBH589 co-treatment. PLoS ONE 6, e20920 (2011).
22. Lee, S. G., Kang, D. C., DeSalle, R., Sarkar, D. & Fisher, P. B. AEG-1/MTDH/ LYRIC, the beginning: initial cloning, structure, expression profile, and regulation of expression. Adv. Cancer Res. 120, 1-38 (2013).
23. Sarkar, D. AEG-1/MTDH/LYRIC in liver cancer. Adv. Cancer Res. 120, 193-221 (2013).
24. Sarkar, D. & Fisher, P. B. AEG-1/MTDH/LYRIC: clinical significance. Adv. Cancer Res. 120, 39-74 (2013).
25. Song, H., Li, C., Li, R. & Geng, J. Prognostic significance of AEG-1 expression in colorectal carcinoma. Int. J. Colorectal Dis. 25, 1201-1209 (2010).
26. Alexia, C. et al. The endoplasmic reticulum acts as a platform for ubiquitylated components of nuclear factor kappaB signaling. Sci. Signal. 6, ra79 (2013).
27. Yoo, B. K. et al. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J. Clin. Investig. 119, 465-477 (2009).
28. Emdad, L. et al. Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration. Pharmacol. Ther. 114, 155-170 (2007).
29. Yu, C. et al. Metadherin regulates metastasis of squamous cell carcinoma of the head and neck via AKT signalling pathway-mediated epithelial-mesenchymal transition. Cancer Lett. 343, 258-267 (2014).
30. Yu, C. et al. Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis 30, 894-901 (2009).
31. Casimiro, S. et al. Metadherin expression and lung relapse in patients with colorectal carcinoma. Clin. Exp. Metastas. 31, 689-696 (2014).
32. Yao, Y. et al. Metadherin regulates proliferation and metastasis via actin cytoskeletal remodelling in non-small cell lung cancer. Br. J. Cancer 111, 355-364 (2014).
33. Emdad, L. et al. Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. Cancer Res. 66, 1509-1516 (2006).
34. Sarkar, D. et al. Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1. Cancer Res. 68, 1478-1484 (2008).
35. Denk, A. et al. Activation of NF-kappa B via the Ikappa B kinase complex is both essential and sufficient for proinflammatory gene expression in primary endothelial cells. J. Biol. Chem. 276, 28451-28458 (2001).
36. Asciutti, S., Akiri, G., Grumolato, L., Vijayakumar, S. & Aaronson, S. A. Diverse mechanisms of Wnt activation and effects of pathway inhibition on proliferation of human gastric carcinoma cells. Oncogene 30, 956-966 (2011).
37. Kulbe, H., Hagemann, T., Szlosarek, P. W., Balkwill, F. R. & Wilson, J. L. The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells. Cancer Res. 65, 10355-10362 (2005).
38. Liang, M., Zhang, P. & Fu, J. Up-regulation of LOX-1 expression by TNF-alpha promotes trans-endothelial migration of MDA-MB-231 breast cancer cells. Cancer Lett. 258, 31-37 (2007).
39. Li, C. et al. Astrocyte elevated gene-1: a novel independent prognostic biomarker for metastatic ovarian tumors. Tumour Biol. 35, 3079-3085 (2014).
40. Guo, J., Xia, B., Meng, F. & Lou, G. miR-137 suppresses cell growth in ovarian cancer by targeting AEG-1. Biochem. Biophys. Res. Commun. 441, 357-363 (2013).
41. Meng, F., Luo, C., Ma, L., Hu, Y. & Lou, G. Clinical significance of astrocyte elevated gene-1 expression in human epithelial ovarian carcinoma. Int. J. Gynecol. Pathol. 30, 145-150 (2011).
42. Cancer Genome Atlas Research, N. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609-615 (2011).
43. Marone, M. et al. Quercetin abrogates taxol-mediated signaling by inhibiting multiple kinases. Exp. Cell Res. 270, 1-12 (2001).
44. Declercq, W., Vanden Berghe, T. & Vandenabeele, P. RIP kinases at the crossroads of cell death and survival. Cell 138, 229-232 (2009).
45. Gasparian, A. V. et al. The role of IKK in constitutive activation of NF-kappaB transcription factor in prostate carcinoma cells. J. Cell Sci. 115, 141-151 (2002).
46. Devalaraja, M. N., Wang, D. Z., Ballard, D. W. & Richmond, A. Elevated constitutive IkappaB kinase activity and IkappaB-alpha phosphorylation in Hs294T melanoma cells lead to increased basal MGSA/GRO-alpha transcription. Cancer Res. 59, 1372-1377 (1999).
47. Bian, Y. et al. An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J. Proteomics 96, 253-262 (2014).
48. Yasuda, T., Saegusa, C., Kamakura, S., Sumimoto, H. & Fukuda, M. Rab27 effector Slp2-a transports the apical signaling molecule podocalyxin to the apical surface of MDCK II cells and regulates claudin-2 expression. Mol. Biol. Cell 23, 3229-3239 (2012).
49. Menasche, G. et al. A newly identified isoform of Slp2a associates with Rab27a in cytotoxic T cells and participates to cytotoxic granule secretion. Blood 112, 5052-5062 (2008).
50. Yoo, B. K. et al. Astrocyte elevated gene-1 (AEG-1): A multifunctional regulator of normal and abnormal physiology. Pharmacol. Ther. 130, 1-8 (2011).
51. Meng, X., Thiel, K. W. & Leslie, K. K. Drug resistance mediated by AEG-1/ MTDH/LYRIC. Adv. Cancer Res. 120, 135-157 (2013).
52. Emdad, L. et al. AEG-1/MTDH/LYRIC: signaling pathways, downstream genes, interacting proteins, and regulation of tumor angiogenesis. Adv. Cancer Res. 120, 75-111 (2013).
53. Karin, M., Yamamoto, Y. & Wang, Q. M. The IKK NF-kappa B system: a treasure trove for drug development. Nat. Rev. Drug Discov. 3, 17-26 (2004).
54. Wu, Y. & Zhou, B. P. TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion. Br. J. Cancer 102, 639-644 (2010).
55. Cavalcanti, Y. V., Brelaz, M. C., Neves, J. K., Ferraz, J. C. & Pereira, V. R. Role of TNF-alpha, IFN-gamma, and IL-10 in the development of pulmonary tuberculosis. Pulm. Med. 2012, 745483 (2012).
56. Chinnaiyan, A. M. et al. FADD/MORT1 is a common mediator of CD95 (Fas/ APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271, 4961-4965 (1996).
57. Swiercz, J. M., Worzfeld, T. & Offermanns, S. ErbB-2 and met reciprocally regulate cellular signaling via plexin-B1. J. Biol. Chem. 283, 1893-1901 (2008).
58. Ong, S. E. et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 1, 376-386 (2002).
59. Swiercz, J. M., Kuner, R., Behrens, J. & Offermanns, S. Plexin-B1 directly interacts with PDZ-RhoGEF/LARG to regulate RhoA and growth cone morphology. Neuron 35, 51-63 (2002).
60. Kobold, S. et al. The macrophage migration inhibitory factor (MIF)-homologue D-dopachrome tautomerase is a therapeutic target in a murine melanoma model. Oncotarget 5, 103-107 (2014).
61. Wisniewski, J. R., Zougman, A. & Mann, M. Combination of FASP and StageTip-based fractionation allows in-depth analysis of the hippocampal membrane proteome. J. Proteome Res. 8, 5674-5678 (2009).
62. Michalski, A. et al. Mass spectrometry-based proteomics using Q Exactive, a high-performance benchtop quadrupole Orbitrap mass spectrometer. Mol. Cell. Proteomics. 10, M111 011015 (2011).
63. Boersema, P. J., Mohammed, S. & Heck, A. J. Phosphopeptide fragmentation and analysis by mass spectrometry. J. Mass Spectrom. 44, 861-878 (2009).
64. Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367-1372 (2008).
65. Cox, J. et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 10, 1794-1805 (2011).
66. Kuhn, M. Building predictive models in R using the caret package. J. Stat. Softw. 28 (2008).
67. Wiener, A. L. a. M. Classification and regression by randomforest. R News 2, 18-22 (2002).
68. Euskirchen, G. M. et al. Mapping of transcription factor binding regions in mammalian cells by ChIP: comparison of array- and sequencing-based technologies. Genome Res. 17, 898-909 (2007).
69. Franken, N. A., Rodermond, H. M., Stap, J., Haveman, J. & van Bree, C. Clonogenic assay of cells in vitro. Nat. Protoc. 1, 2315-2319 (2006).
70. Tusher, V. G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl Acad. Sci. USA 98, 5116-5121 (2001).